Kronos Bio Statistics
Total Valuation
FRA:AM8 has a market cap or net worth of EUR 853.39 million. The enterprise value is 1.24 billion.
Market Cap | 853.39M |
Enterprise Value | 1.24B |
Important Dates
The last earnings date was Thursday, July 24, 2025.
Earnings Date | Jul 24, 2025 |
Ex-Dividend Date | Apr 17, 2025 |
Share Statistics
Current Share Class | 35.26M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.13% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 6.35M |
Valuation Ratios
The trailing PE ratio is 25.70 and the forward PE ratio is 26.99.
PE Ratio | 25.70 |
Forward PE | 26.99 |
PS Ratio | 0.56 |
PB Ratio | 1.16 |
P/TBV Ratio | 1.19 |
P/FCF Ratio | 16.45 |
P/OCF Ratio | 7.14 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.56, with an EV/FCF ratio of 23.89.
EV / Earnings | 37.31 |
EV / Sales | 0.81 |
EV / EBITDA | 8.56 |
EV / EBIT | 27.33 |
EV / FCF | 23.89 |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.79.
Current Ratio | 2.46 |
Quick Ratio | 1.12 |
Debt / Equity | 0.79 |
Debt / EBITDA | 4.03 |
Debt / FCF | 11.23 |
Interest Coverage | 2.08 |
Financial Efficiency
Return on equity (ROE) is 4.53% and return on invested capital (ROIC) is 2.19%.
Return on Equity (ROE) | 4.53% |
Return on Assets (ROA) | 1.71% |
Return on Invested Capital (ROIC) | 2.19% |
Return on Capital Employed (ROCE) | 3.51% |
Revenue Per Employee | 689,528 |
Profits Per Employee | 14,993 |
Employee Count | 2,192 |
Asset Turnover | 0.93 |
Inventory Turnover | 3.02 |
Taxes
In the past 12 months, FRA:AM8 has paid 17.97 million in taxes.
Income Tax | 17.97M |
Effective Tax Rate | 35.11% |
Stock Price Statistics
The stock price has decreased by -2.43% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -2.43% |
50-Day Moving Average | 24.23 |
200-Day Moving Average | 24.27 |
Relative Strength Index (RSI) | 46.99 |
Average Volume (20 Days) | 194 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:AM8 had revenue of EUR 1.53 billion and earned 33.21 million in profits. Earnings per share was 0.94.
Revenue | 1.53B |
Gross Profit | 219.73M |
Operating Income | 45.15M |
Pretax Income | 51.18M |
Net Income | 33.21M |
EBITDA | 142.87M |
EBIT | 45.15M |
Earnings Per Share (EPS) | 0.94 |
Balance Sheet
The company has 196.86 million in cash and 582.49 million in debt, giving a net cash position of -385.63 million.
Cash & Cash Equivalents | 196.86M |
Total Debt | 582.49M |
Net Cash | -385.63M |
Net Cash Per Share | n/a |
Equity (Book Value) | 735.96M |
Book Value Per Share | 20.87 |
Working Capital | 546.14M |
Cash Flow
In the last 12 months, operating cash flow was 119.57 million and capital expenditures -67.70 million, giving a free cash flow of 51.87 million.
Operating Cash Flow | 119.57M |
Capital Expenditures | -67.70M |
Free Cash Flow | 51.87M |
FCF Per Share | n/a |
Margins
Gross margin is 14.39%, with operating and profit margins of 2.96% and 2.17%.
Gross Margin | 14.39% |
Operating Margin | 2.96% |
Pretax Margin | 3.35% |
Profit Margin | 2.17% |
EBITDA Margin | 9.35% |
EBIT Margin | 2.96% |
FCF Margin | 3.40% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 4.98%.
Dividend Per Share | 1.20 |
Dividend Yield | 4.98% |
Dividend Growth (YoY) | -20.00% |
Years of Dividend Growth | n/a |
Payout Ratio | 127.43% |
Buyback Yield | n/a |
Shareholder Yield | 4.98% |
Earnings Yield | 3.89% |
FCF Yield | 6.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
FRA:AM8 has an Altman Z-Score of 2.21 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.21 |
Piotroski F-Score | 6 |